메뉴 건너뛰기




Volumn 6, Issue 6, 2004, Pages 459-467

Estrogens and stroke: Use of oral contraceptives and postmenopausal use of estrogen: Current recommendations

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TESTOSTERONE;

EID: 9244260509     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-004-0004-9     Document Type: Review
Times cited : (7)

References (54)
  • 1
    • 0026451056 scopus 로고
    • Secular trends in stroke incidence and mortality
    • Wolf PA, D'Agostino RB, O'Neal A, et al.: Secular trends in stroke incidence and mortality. Stroke 1992, 23: 551-1555.
    • (1992) Stroke , vol.23 , pp. 1551-1555
    • Wolf, P.A.1    D'Agostino, R.B.2    O'Neal, A.3
  • 2
    • 0037319445 scopus 로고    scopus 로고
    • Estrogen and stroke: A balanced analysis
    • Hurn PD, Brass LM: Estrogen and stroke: A balanced analysis. Stroke 2003, 34:338-341.
    • (2003) Stroke , vol.34 , pp. 338-341
    • Hurn, P.D.1    Brass, L.M.2
  • 4
    • 0033304765 scopus 로고    scopus 로고
    • Estrogen actions in the centeral nervous system
    • McEwen BS, Alves SE: Estrogen actions in the centeral nervous system. Endocr Rev 1999, 20:279-307.
    • (1999) Endocr. Rev. , vol.20 , pp. 279-307
    • McEwen, B.S.1    Alves, S.E.2
  • 5
    • 0035680512 scopus 로고    scopus 로고
    • The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors
    • Walsh BW: The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors. Ann N Y Acad Sci 2001, 949:163-167.
    • (2001) Ann. N. Y. Acad. Sci. , vol.949 , pp. 163-167
    • Walsh, B.W.1
  • 6
    • 0033542402 scopus 로고    scopus 로고
    • The protective effects of estrogen on the cardiovascular system
    • Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999, 340:1801-1811.
    • (1999) N. Engl. J. Med. , vol.340 , pp. 1801-1811
    • Mendelsohn, M.E.1    Karas, R.H.2
  • 7
    • 0038268485 scopus 로고    scopus 로고
    • Estrogen and ischemic neuroprotection: An integrated review
    • McCullough LD, Hurn PD: Estrogen and ischemic neuroprotection: an integrated review. Trends Endocrinol Metab 2003, 14:228-235.
    • (2003) Trends Endocrinol. Metab. , vol.14 , pp. 228-235
    • McCullough, L.D.1    Hurn, P.D.2
  • 9
    • 1842681509 scopus 로고    scopus 로고
    • Risk of stroke in women exposed to low-dose oral contraceptives: A critical evaluation of the evidence
    • Chan WS, Ray J, Wai EK, et al.: Risk of stroke in women exposed to low-dose oral contraceptives: A critical evaluation of the evidence. Arch Int Med 2004, 164:741-474.
    • (2004) Arch. Int. Med. , vol.164 , pp. 741-744
    • Chan, W.S.1    Ray, J.2    Wai, E.K.3
  • 10
    • 0031720090 scopus 로고    scopus 로고
    • Bias versus causality: Interpreting recent evidence of oral contraceptive studies
    • Spitzer WO: Bias versus causality: Interpreting recent evidence of oral contraceptive studies. Am J Obstet and Gynecol 1998, 179(suppl 3):43S-50S.
    • (1998) Am. J. Obstet. and Gynecol. , vol.179 , Issue.SUPPL. 3
    • Spitzer, W.O.1
  • 11
    • 0031789242 scopus 로고    scopus 로고
    • Stroke and use of low-dose oral contraceptives in young women: A pooled analysis of two US studies
    • Schwartz SM, Petitti DB, Siscovick DS, et al.: Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke. 1998, 29:2277-2284.
    • (1998) Stroke , vol.29 , pp. 2277-2284
    • Schwartz, S.M.1    Petitti, D.B.2    Siscovick, D.S.3
  • 12
    • 0030698660 scopus 로고    scopus 로고
    • Case-control study of oral contraceptives and risk of thromboembolic stroke: Results from Internation Study of Oral Contraceptives and Health of Young Women
    • Heinemann LAJ, Lewis MA, Thorogood M, et al.: Case-control study of oral contraceptives and risk of thromboembolic stroke: Results from Internation Study of Oral Contraceptives and Health of Young Women. BMJ. 1997, 315:1502-1504.
    • (1997) BMJ , vol.315 , pp. 1502-1504
    • Heinemann, L.A.J.1    Lewis, M.A.2    Thorogood, M.3
  • 13
    • 0030600340 scopus 로고    scopus 로고
    • Ischemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception:
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Ischemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study. Lancet 1996, 348:498-505.
    • (1996) Lancet , vol.348 , pp. 498-505
  • 14
    • 0034608911 scopus 로고    scopus 로고
    • Ischemic stroke risk with oral contraceptives
    • Gillum LA, Mamidipudi SK, Johnson SC: Ischemic stroke risk with oral contraceptives. Stroke 2000, 284:72-78.
    • (2000) Stroke , vol.284 , pp. 72-78
    • Gillum, L.A.1    Mamidipudi, S.K.2    Johnson, S.C.3
  • 15
  • 16
    • 0030600339 scopus 로고    scopus 로고
    • Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multi-centre, case-control study
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception:
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: Results of an international, multi-centre, case-control study. Lancet 1996, 348:505-510.
    • (1996) Lancet , vol.348 , pp. 505-510
  • 17
    • 0003528179 scopus 로고    scopus 로고
    • Cardiovascular disease and steroid hormone contraception: Report of the World Health Organization scientific group
    • World Health Organization Scientific Group on Cardiovascular Disease and Steroid Hormone Contraception: Geneva: World Health Organization
    • World Health Organization Scientific Group on Cardiovascular Disease and Steroid Hormone Contraception: Cardiovascular disease and steroid hormone contraception: report of the World Health Organization scientific group. In World Health Organization Technical Report Series: 877. Geneva: World Health Organization; 1998.
    • (1998) World Health Organization Technical Report Series , vol.877
  • 18
    • 0030874726 scopus 로고    scopus 로고
    • Epidemiology and etiology of ischaemic stroke in young adults aged 18 to 44 years in Northern Sweden
    • Kristensen B, Malm J, Calberg B, et al.: Epidemiology and etiology of ischaemic stroke in young adults aged 18 to 44 years in Northern Sweden. Stroke 1997, 28:1702-1709.
    • (1997) Stroke , vol.28 , pp. 1702-1709
    • Kristensen, B.1    Malm, J.2    Calberg, B.3
  • 20
    • 3042684298 scopus 로고    scopus 로고
    • Ischemic stroke in young women: A nested-case control study using the UK General Practice Research database
    • Nightinggale AL, Farmer RDT: Ischemic stroke in young women: A nested-case control study using the UK General Practice Research database. Stroke 2004, 35:1574-1578.
    • (2004) Stroke , vol.35 , pp. 1574-1578
    • Nightinggale, A.L.1    Farmer, R.D.T.2
  • 22
    • 0037422851 scopus 로고    scopus 로고
    • Prescribing oral contraceptives for women older than 35 years of age
    • Selbert C, Barbouche E, Fagan J, et al.: Prescribing oral contraceptives for women older than 35 years of age. Ann Intern Med 2003, 138:54-64.
    • (2003) Ann. Intern. Med. , vol.138 , pp. 54-64
    • Selbert, C.1    Barbouche, E.2    Fagan, J.3
  • 23
    • 0034453872 scopus 로고    scopus 로고
    • Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine
    • The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy
    • Bousser MG, Conard J, Kittner S, et al.: Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 2000, 20:155-160.
    • (2000) Cephalalgia , vol.20 , pp. 155-160
    • Bousser, M.G.1    Conard, J.2    Kittner, S.3
  • 25
    • 0033009698 scopus 로고    scopus 로고
    • Oral contraceptives and smoking, current considerations: Recommendations of a consensus panel
    • Schiff I, Bell WR, Davis V, et al.: Oral contraceptives and smoking, current considerations: recommendations of a consensus panel. Am J Obstet Gynecol 1999, 180:S383-S384.
    • (1999) Am. J. Obstet. Gynecol. , vol.180
    • Schiff, I.1    Bell, W.R.2    Davis, V.3
  • 26
    • 0025944051 scopus 로고
    • Postmenopausal estrogen and prevention bias
    • Barrett-Connor E: Postmenopausal estrogen and prevention bias. Ann Int Med 1991, 115:455-456.
    • (1991) Ann. Int. Med. , vol.115 , pp. 455-456
    • Barrett-Connor, E.1
  • 27
    • 0025984375 scopus 로고
    • Discussing hidden bias in observational studies
    • Rosenbaum PR: Discussing hidden bias in observational studies. Ann Int Med 1991, 115:901-905.
    • (1991) Ann. Int. Med. , vol.115 , pp. 901-905
    • Rosenbaum, P.R.1
  • 28
    • 0018736142 scopus 로고
    • Bias in analytic research
    • Sackett DL. Bias in analytic research. J Chronic Dis 1979, 32:51-63.
    • (1979) J. Chronic Dis. , vol.32 , pp. 51-63
    • Sackett, D.L.1
  • 29
    • 0037125379 scopus 로고    scopus 로고
    • Risk and benefits of estrogen plus progestin in health postmenopausal women
    • Writing Group for the Women's Health Initiative Investigators:
    • Writing Group for the Women's Health Initiative Investigators: Risk and benefits of estrogen plus progestin in health postmenopausal women. JAMA 2002, 288:321-333.
    • (2002) JAMA , vol.288 , pp. 321-333
  • 30
    • 1842867053 scopus 로고    scopus 로고
    • Effects of conjugated equine estrogen in post-menopausal women with hysterectomy
    • Writing Group for the Women's Health Initiative Investigators
    • Writing Group for the Women's Health Initiative Investigators. Effects of conjugated equine estrogen in post-menopausal women with hysterectomy. JAMA 2004, 291: 701-1712.
    • (2004) JAMA , vol.291 , pp. 1701-1712
  • 31
    • 0037830132 scopus 로고    scopus 로고
    • Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initative Randomized Trial
    • Chlebowski RT, Hendrix SL, Langer RD, et al.: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initative Randomized Trial. JAMA 2003, 289:3243-3253.
    • (2003) JAMA , vol.289 , pp. 3243-3253
    • Chlebowski, R.T.1    Hendrix, S.L.2    Langer, R.D.3
  • 32
    • 10744230501 scopus 로고    scopus 로고
    • Evidence-based guidelines for cardiovascular disease prevention in women
    • Mosca L, Appel LJ, Benjamin EJ, et al.: Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004, 109:672-693.
    • (2004) Circulation , vol.109 , pp. 672-693
    • Mosca, L.1    Appel, L.J.2    Benjamin, E.J.3
  • 33
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    • Hulley S, Grady D, Bush T, et al.: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998, 280:605-611.
    • (1998) JAMA , vol.280 , pp. 605-611
    • Hulley, S.1    Grady, D.2    Bush, T.3
  • 34
    • 0035814748 scopus 로고    scopus 로고
    • Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)
    • Simon JA, Hsia J, Cauley JA, et al.: Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation 2001, 103:638-642.
    • (2001) Circulation , vol.103 , pp. 638-642
    • Simon, J.A.1    Hsia, J.2    Cauley, J.A.3
  • 35
    • 0035950682 scopus 로고    scopus 로고
    • A clinical trial of estrogen-replacement therapy after ischemic stroke
    • Viscoli CM, Brass LM, Kernan WN, et al.: A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001, 345:1243-1249.
    • (2001) N. Engl. J. Med. , vol.345 , pp. 1243-1249
    • Viscoli, C.M.1    Brass, L.M.2    Kernan, W.N.3
  • 36
    • 0003070216 scopus 로고    scopus 로고
    • Estrogen after ischemic stroke: Clinical basis and design of the Women's Estrogen for Stroke Trial
    • Kernan WN, Brass LM, Viscoli CM, et al.: Estrogen after ischemic stroke: Clinical basis and design of the Women's Estrogen for Stroke Trial. J Stroke Cerebrovasc Dis 1997, 7:85-95.
    • (1997) J. Stroke Cerebrovasc. Dis. , vol.7 , pp. 85-95
    • Kernan, W.N.1    Brass, L.M.2    Viscoli, C.M.3
  • 37
    • 0035943052 scopus 로고    scopus 로고
    • Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
    • Mosca L, Collins P, Herrington DM, et al.: Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 2001, 104:499-503.
    • (2001) Circulation , vol.104 , pp. 499-503
    • Mosca, L.1    Collins, P.2    Herrington, D.M.3
  • 38
    • 0742318858 scopus 로고    scopus 로고
    • Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results
    • Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K: Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004, 140:184-188.
    • (2004) Ann. Intern. Med. , vol.140 , pp. 184-188
    • Haas, J.S.1    Kaplan, C.P.2    Gerstenberger, E.P.3    Kerlikowske, K.4
  • 39
    • 0141705375 scopus 로고    scopus 로고
    • Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initative Randomized Trial
    • Cauley JA, Robbins J, Chen Z, et al.: Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initative Randomized Trial. JAMA 2003, 290: 729-1738.
    • (2003) JAMA , vol.290 , pp. 1729-1738
    • Cauley, J.A.1    Robbins, J.2    Chen, Z.3
  • 40
    • 2942755831 scopus 로고    scopus 로고
    • Congugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmonopausal women: Women's Heart Initiative Memory Study
    • Shumaker SA, Legault C, Kuller L, et al.: Congugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmonopausal women: Women's Heart Initiative Memory Study. JAMA 2004, 2947-2958.
    • (2004) JAMA , pp. 2947-2958
    • Shumaker, S.A.1    Legault, C.2    Kuller, L.3
  • 41
    • 2942750157 scopus 로고    scopus 로고
    • Conjugated equine estrogen and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study
    • Espeland MA, Rapp SR, Shumaker SA, et al.: Conjugated equine estrogen and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291:2959-2968.
    • (2004) JAMA , vol.291 , pp. 2959-2968
    • Espeland, M.A.1    Rapp, S.R.2    Shumaker, S.A.3
  • 42
    • 0013903077 scopus 로고
    • An evaluation of estrogenic substances in the treatment of cerebral vascular disease
    • Veterans Administration Cooperative Study of Atherosclerosis:
    • Veterans Administration Cooperative Study of Atherosclerosis: An evaluation of estrogenic substances in the treatment of cerebral vascular disease. Circulation 1966, 33(suppl 2):3-9.
    • (1966) Circulation , vol.33 , Issue.SUPPL. 2 , pp. 3-9
  • 43
    • 1642458222 scopus 로고    scopus 로고
    • Risks of testosterone-replacement therapy and recommendations for monitoring
    • Rhoden EL, Morgentaler A: Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004, 350:482-492.
    • (2004) N. Engl. J. Med. , vol.350 , pp. 482-492
    • Rhoden, E.L.1    Morgentaler, A.2
  • 44
    • 2442422178 scopus 로고    scopus 로고
    • Endogenous sex hormones and progression of carotid atherosclosis in elderly men
    • Muller M, van den Beld AW, Bots ML, et al.: Endogenous sex hormones and progression of carotid atherosclosis in elderly men. Circulation 2004, 109:2074-2079.
    • (2004) Circulation , vol.109 , pp. 2074-2079
    • Muller, M.1    van den Beld, A.W.2    Bots, M.L.3
  • 46
    • 0036357643 scopus 로고    scopus 로고
    • Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo study
    • Oh JY, Barrett-Connor E, Wedick NM, Wingard DL: Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002, 25: 5-60.
    • (2002) Diabetes Care , vol.25 , pp. 55-60
    • Oh, J.Y.1    Barrett-Connor, E.2    Wedick, N.M.3    Wingard, D.L.4
  • 47
    • 0034595197 scopus 로고    scopus 로고
    • Postmenopausal hormone therapy increases the risk for venous thromboembolic disease
    • Grady D, Wenger NK, Herrington D, et al.: Postmenopausal hormone therapy increases the risk for venous thromboembolic disease. Ann Intern Med 2000, 132:689-696.
    • (2000) Ann. Intern. Med. , vol.132 , pp. 689-696
    • Grady, D.1    Wenger, N.K.2    Herrington, D.3
  • 48
    • 0033515045 scopus 로고    scopus 로고
    • Clinical effects of raloxifene hydrochloride in women
    • Khovidhunkit W, Shoback DM: Clinical effects of raloxifene hydrochloride in women. Arch Int Med 1999, 130:431-439.
    • (1999) Arch. Int. Med. , vol.130 , pp. 431-439
    • Khovidhunkit, W.1    Shoback, D.M.2
  • 49
    • 0037434618 scopus 로고    scopus 로고
    • Selective estrogen-receptor modulators - Mechanisms of action and application to clinical practice
    • Riggs BL, Hartmann LC: Selective estrogen-receptor modulators - Mechanisms of action and application to clinical practice. N Engl J Med 2003, 348:618-629.
    • (2003) N. Engl. J. Med. , vol.348 , pp. 618-629
    • Riggs, B.L.1    Hartmann, L.C.2
  • 50
    • 3042851662 scopus 로고    scopus 로고
    • Cardiovascular effects of raloxifene: The arterial and venous systems
    • Blumenthal RS, Baranowski B, Dowsett SA: Cardiovascular effects of raloxifene: The arterial and venous systems. Am Heart J 2004, 147:783-789.
    • (2004) Am. Heart J. , vol.147 , pp. 783-789
    • Blumenthal, R.S.1    Baranowski, B.2    Dowsett, S.A.3
  • 51
    • 0034626064 scopus 로고    scopus 로고
    • Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Assessment of liver and endometrial cancer risk following tamoxifen
    • Comprehensive Cancer Centres' ALERT Group
    • Bergman L, Beelen ML, Gallee MP, et al.: Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet 2000, 356:881-887.
    • (2000) Lancet , vol.356 , pp. 881-887
    • Bergman, L.1    Beelen, M.L.2    Gallee, M.P.3
  • 52
    • 0036890079 scopus 로고    scopus 로고
    • Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) Trial
    • Wenger NK, Barrett-Connor E, Collins P, et al.: Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) Trial. Am J Cardiol 2002, 90:1204-1210.
    • (2002) Am. J. Cardiol. , vol.90 , pp. 1204-1210
    • Wenger, N.K.1    Barrett-Connor, E.2    Collins, P.3
  • 53
    • 0037138787 scopus 로고    scopus 로고
    • Raloxifine and cardiovascular events in osteoporotic postmenopausal women. Four year results from the MORE
    • (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial
    • Barrett-Connor E, Grady D, Sashegyi A, et al.: Raloxifine and cardiovascular events in osteoporotic postmenopausal women. Four year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial. JAMA 2002, 287:847-857.
    • (2002) JAMA , vol.287 , pp. 847-857
    • Barrett-Connor, E.1    Grady, D.2    Sashegyi, A.3
  • 54
    • 0035880662 scopus 로고    scopus 로고
    • Design and methods of the Raloxifene Use for The Heart (RUTH) study
    • Mosca L, Barrett-Connor E, Wenger NK, et al.: Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol 2001, 88:392-395.
    • (2001) Am. J. Cardiol. , vol.88 , pp. 392-395
    • Mosca, L.1    Barrett-Connor, E.2    Wenger, N.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.